88 related articles for article (PubMed ID: 15013752)
21. Characterization and expression of the transcription factor PU.1 during LPS-induced inflammation in the rainbow trout (Oncorhynchus mykiss).
Ribas L; Roher N; Martínez M; Balasch JC; Doñate C; Goetz FW; Iliev D; Planas JV; Tort L; Mackenzie S
Fish Shellfish Immunol; 2008 Jan; 24(1):35-45. PubMed ID: 18083598
[TBL] [Abstract][Full Text] [Related]
22. Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1.
Mouri F; Tsukada J; Mizobe T; Higashi T; Yoshida Y; Minami Y; Izumi H; Kominato Y; Kohno K; Tanaka Y
Eur J Haematol; 2008 Jan; 80(1):10-9. PubMed ID: 18173740
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells.
Turner EC; Kinsella BT
J Mol Biol; 2009 Feb; 386(3):579-97. PubMed ID: 19118563
[TBL] [Abstract][Full Text] [Related]
24. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
Kastner P; Chan S
Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
26. Cartography of hematopoietic stem cell commitment dependent upon a reporter for transcription factor activation.
Akashi K
Ann N Y Acad Sci; 2007 Jun; 1106():76-81. PubMed ID: 17360807
[TBL] [Abstract][Full Text] [Related]
27. PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages.
Schroder K; Lichtinger M; Irvine KM; Brion K; Trieu A; Ross IL; Ravasi T; Stacey KJ; Rehli M; Hume DA; Sweet MJ
J Leukoc Biol; 2007 Jun; 81(6):1577-90. PubMed ID: 17360957
[TBL] [Abstract][Full Text] [Related]
28. Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells.
Delva L; Gallais I; Guillouf C; Denis N; Orvain C; Moreau-Gachelin F
Oncogene; 2004 May; 23(25):4389-99. PubMed ID: 15064749
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites.
Bondeva T; Roger T; Wolf G
Am J Nephrol; 2007; 27(3):308-14. PubMed ID: 17495427
[TBL] [Abstract][Full Text] [Related]
30. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
31. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
[TBL] [Abstract][Full Text] [Related]
32. Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia.
Suraweera N; Meijne E; Moody J; Carvajal-Carmona LG; Yoshida K; Pollard P; Fitzgibbon J; Riches A; van Laar T; Huiskamp R; Rowan A; Tomlinson IP; Silver A
Oncogene; 2005 May; 24(22):3678-83. PubMed ID: 15750630
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the promoter region of the human PARG gene and its response to PU.1 during differentiation of HL-60 cells.
Uchiumi F; Sakakibara G; Sato J; Tanuma S
Genes Cells; 2008 Dec; 13(12):1229-47. PubMed ID: 19076642
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
[TBL] [Abstract][Full Text] [Related]
35. Lineage switch induced by overexpression of Ets family transcription factor PU.1 in murine erythroleukemia cells.
Yamada T; Abe M; Higashi T; Yamamoto H; Kihara-Negishi F; Sakurai T; Shirai T; Oikawa T
Blood; 2001 Apr; 97(8):2300-7. PubMed ID: 11290591
[TBL] [Abstract][Full Text] [Related]
36. Surprising new roles for PU.1 in the adaptive immune response.
Carotta S; Wu L; Nutt SL
Immunol Rev; 2010 Nov; 238(1):63-75. PubMed ID: 20969585
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells.
Yamada T; Kondoh N; Matsumoto M; Yoshida M; Maekawa A; Oikawa T
Blood; 1997 Feb; 89(4):1383-93. PubMed ID: 9028962
[TBL] [Abstract][Full Text] [Related]
38. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors.
Scott EW; Fisher RC; Olson MC; Kehrli EW; Simon MC; Singh H
Immunity; 1997 Apr; 6(4):437-47. PubMed ID: 9133423
[TBL] [Abstract][Full Text] [Related]
39. Normal myeloid development requires both the glutamine-rich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain.
Fisher RC; Olson MC; Pongubala JM; Perkel JM; Atchison ML; Scott EW; Simon MC
Mol Cell Biol; 1998 Jul; 18(7):4347-57. PubMed ID: 9632818
[TBL] [Abstract][Full Text] [Related]
40. PU.1 phosphorylation correlates with hydroquinone-induced alterations in myeloid differentiation and cytokine-dependent clonogenic response in human CD34(+) hematopoietic progenitor cells.
Gross SA; Zheng JH; Le AT; Kerzic PJ; Irons RD
Cell Biol Toxicol; 2006 Jul; 22(4):229-41. PubMed ID: 16642264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
